ServisFirst Bancshares, Inc. Announces Results for Fourth Quarter of 2025

ServisFirst Bancshares, Inc. Announces Results for Fourth Quarter of 2025 GlobeNewswire January 20, 2026 BIRMINGHAM, Ala., Jan. 20, 2026 (GLOBE NEWSWIRE) — ServisFirst Bancshares, Inc. (NYSE: SFBS), today announced earnings and operating results for the quarter ended December 31, 2025. Fourth Quarter 2025 Highlights: Diluted earnings per share of $5.06 for 2025, up 22% over […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc – MREO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc – MREO GlobeNewswire January 20, 2026 NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to

Upwork to Report Fourth Quarter and Full Year 2025 Financial Results on February 9, 2026

(NASDAQ:UPWK), PALO ALTO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world's human and AI-powered work marketplace, today announced that it will report its financial results for the fourth quarter and full year of 2025 on Monday, February 9, 2026 after market close. The company will host a Q&A conference call

Upwork to Report Fourth Quarter and Full Year 2025 Financial Results on February 9, 2026

Upwork to Report Fourth Quarter and Full Year 2025 Financial Results on February 9, 2026 GlobeNewswire January 20, 2026 PALO ALTO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world's human and AI-powered work marketplace, today announced that it will report its financial results for the fourth quarter and full year

LevelJump Enters into Cooperation Agreement with Concerned Shareholder; Announces Board Reconstitution

Toronto, Ontario–(Newsfile Corp. – January 20, 2026) – LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (“LevelJump” or the “Company”), a leading provider of teleradiology and diagnostic imaging services, today announced that it has entered into a cooperation agreement (the “Agreement”) with Frank Teti. Under the terms of the Agreement, LevelJump has agreed to a

Earlyworks Closes Acquisition and Rebrands as Perpetuals.com (NASDAQ – PDC), Targeting the Multi-Trillion-Dollar Global Derivatives Market

NVIDIA AIâ?’Powered, Blockchainâ?’Native Trading Platform Designed to Bridge Traditional Finance and Crypto at Global Scale TOKYO, JAPAN / ACCESS Newswire / January 20, 2026 / Earlyworks Co., Ltd. (NASDAQ:PDC) today announced the successful completion of its acquisition of Perpetual Markets Ltd. Accordingly, the company has rebranded as Perpetuals.com Ltd and its Nasdaq ticker symbol has

Canon Ranked Seventh in U.S. Patent Ranking, now in the Top10 for 42 Years Running

MELVILLE, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) — Canon U.S.A. Inc., a leader in digital imaging solutions, today announced that its parent company, Canon Inc., ranked seventh in the number of patents granted by the United States Patent and Trademark Office (USPTO) in 2025, placing it in the world's top 10, according to IFI CLAIMS

Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic

(AUST:AVR.AX),(NasdaqGM:AVR), MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (“Anteris” or the “Company“) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced that it is offering to sell, subject to market and other

Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

(NasdaqGM:CRVS), SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common

Scroll to Top